Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NovoCure Ltd | General Counsel | Stock Options (Right to buy) | 125K | $2.04M | $16.30 | Feb 27, 2024 | Direct |
NovoCure Ltd | General Counsel | Ordinary Shares | 118K | $1.44M | $12.24 | Jun 28, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVCR | NovoCure Ltd | Jun 28, 2024 | 1 | $11.4K | 4 | Aug 6, 2024 | General Counsel |
NVCR | NovoCure Ltd | Feb 27, 2024 | 3 | $3.37M | 4 | Feb 29, 2024 | General Counsel |
NVCR | NovoCure Ltd | Jun 30, 2023 | 1 | $10.2K | 4 | Jul 6, 2023 | General Counsel |
NVCR | NovoCure Ltd | Feb 28, 2023 | 2 | $2.27M | 4 | Mar 2, 2023 | General Counsel |
NVCR | NovoCure Ltd | Jan 6, 2023 | 1 | $9.35K | 4 | Jan 10, 2023 | General Counsel |
NVCR | NovoCure Ltd | Jul 5, 2022 | 1 | $8.51K | 4 | Jul 7, 2022 | General Counsel |
NVCR | NovoCure Ltd | Apr 14, 2022 | 0 | $0 | 3 | Apr 14, 2022 | General Counsel |